![]() |
|
|
Vol. 20, Issue 15, 3491-3502, August 1, 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

,
,
*Institut National de la Santé et de la Recherche Médicale, Université Joseph Fourier-Grenoble 1, and Institut Albert Bonniot U823, Site Santé-BP 170, 38042 Grenoble, France;
Institut de Biologie Structurale Jean Pierre Ebel (Commissariat à l'Energie Atomique/Centre National de la Recherche Scientifique/Université Joseph Fourier), 38027 Grenoble Cedex 1, France; and
Sidney Kimmel Cancer Center, San Diego, CA 92121
Submitted May 6, 2009;
Revised May 19, 2009;
Accepted May 22, 2009
Monitoring Editor: Daniel J. Lew
Aurora A and Aurora B, paralogue mitotic kinases, share highly similar primary sequence. Both are important to mitotic progression, but their localizations and functions are distinct. We have combined shRNA suppression with overexpression of Aurora mutants to address the cause of the distinction between Aurora A and Aurora B. Aurora A residue glycine 198 (G198), mutated to asparagine to mimic the aligned asparagine 142 (N142) of Aurora B, causes Aurora A to bind the Aurora B binding partner INCENP but not the Aurora A binding partner TPX2. The mutant Aurora A rescues Aurora B mitotic function. We conclude that binding to INCENP is alone critical to the distinct function of Aurora B. Although G198 of Aurora A is required for TPX2 binding, N142G Aurora B retains INCENP binding and Aurora B function. Thus, although a single residue change transforms Aurora A, the reciprocal mutation of Aurora B does not create Aurora A function. An Aurora A-
120 N-terminal truncation construct reinforces Aurora A similarity to Aurora B, because it does not associate with centrosomes but instead associates with kinetochores.
These authors have contributed equally to this work.
Address correspondence to: Robert L. Margolis (rmargolis{at}skcc.org) or Stefan Dimitrov (stefan.dimitrov{at}ujf-grenoble.fr)
Abbreviations used: AurA, Aurora A; AurB, Aurora B; HA, hemagglutinin; shRNA, small hairpin RNA.